If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Indian companies significantly boosted overseas investments in April. Direct investments surged to $3.37 billion, more than doubling from M...

Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...

Zydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. T...

Indian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL,...

Indian drug maker Zydus Lifesciences is close to acquiring a US company. The deal is expected to be between $100 to $150 million. This acqu...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...

Bain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...

Indian consumer sector investment declined in FY26. Investors are now favoring smaller, diversified deals over large bets. Deal volume, how...

Zydus Lifesciences is set to acquire Agenus Inc.'s biologics manufacturing facilities in California for $75 million upfront and $50 million...

An arm of the British banking group is learnt to have bought out the entire Rs 500-crore zero-coupon bond offering by Rare Equity Private L...

“In our view, this is a win-win deal for both Zydus and Heinz; Heinz will now likely focus on its global portfolio, ketchup and mayonnaise,...

Shares of Everonn Education ended firm in a falling market on Monday, after the company signed a JV agreement with India’s National Skill D...

Ahmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...

Sharekhan has recommended ‘buy’ on Cadila Healthcare with a target price of Rs.372. At the current market price of Rs272, the stock is avai...

The Ahmedabad-based pharma major Zydus Cadila on Tuesday said it has acquired Etna Biotech, a subsidiary of the Dutch biopharma company, Cr...